HS

Hans-Harald Sedlacek

AG Aventis Pharma Deutschland Gmbh: 3 patents #13 of 187Top 7%
📍 Freising, DE: #1 of 30 inventorsTop 4%
Overall (2003): #16,587 of 273,478Top 7%
4
Patents 2003

Issued Patents 2003

Showing 1–4 of 4 patents

Patent #TitleCo-InventorsDate
6670147 Nucleic acid construct for expressing active substances which can be activated by proteases, and preparation and use Hans Heinrich Heidtmann, Rolf Mueller 2003-12-30
6610299 Glycosyl-etoposide prodrugs, a process for preparation thereof and the use thereof in combination with functionalized tumor-specific enzyme conjugates Cenek Kolar, Jorg Czech, Klaus Bosslet, Gerhard Seemann, Dieter Hoffmann 2003-08-26
6576758 Nucleic acid constructs containing hybrid promoters Klaus-Heinrich Seifart, Rolf Mueller 2003-06-10
6548067 Antigenic constructs of major histocompatibility complex class I antigens with specific carrier molecules, the preparation and use thereof Gerhard Seeman, Klaus Bosslet 2003-04-15